"L’Institut de Cancérologie de l’Ouest (ICO) est un Centre de Lutte Contre le Cancer qui a pour mission le soin, la recherche et l’enseignement.Du diagnostic rapide à la chirurgie, la chimiothérapie, la radiothérapie, la prise en charge s'étend également aux soins de support. Spécialisés en cancérologie, les professionnels de l'ICO accompagnent les patients à toutes les étapes de leur parcours de soins, de manière personnalisée, innovante et multidisciplinaire. Consultations sans dépassement d’honoraires."

During the past decade, Centre Regional Rene Gauducheau conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Regional Rene Gauducheau" #1 sponsor was "UNICANCER" with 19 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Centre Paul Strauss" with 1 trials sponsored, "Medical Research Council" with 1 trials sponsored and "National Cancer Institute, France" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Regional Rene Gauducheau" #1 collaborator was "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Anglo Celtic Cooperative Oncology Group" with 1 trials as a collaborator, "British Medical Research Council" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Central European Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Centre Regional Rene Gauducheau" are "Breast Cancer" (11 trials), "Brain and Central Nervous System Tumors" (3 trials), "Pancreatic Cancer" (3 trials), "Sarcoma" (3 trials) and "Anal Cancer" (2 trials). Many other conditions were trialed in "Centre Regional Rene Gauducheau" in a lesser frequency.

Most popular intervention types in "Centre Regional Rene Gauducheau" are "Drug" (27 trials), "Procedure" (12 trials), "Radiation" (9 trials), "Biological" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (9 trials), "radiation therapy" (7 trials), "cisplatin" (5 trials), "cyclophosphamide" (5 trials) and "docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Centre Regional Rene Gauducheau" are 16 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Regional Rene Gauducheau". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Centre Regional Rene Gauducheau, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Regional Rene Gauducheau, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".